MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer, will participate at the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12, 2021 at 4:30 p.m. ET.
A live webcast of Dr. Marsolais’ presentation will be available through the ‘Events’ section of the Company’s investor relations website and will be archived for 90 days.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries:
Leah Gibson
Senior Director, Investor Relations
communications@theratech.com
617-356-1009
Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…
NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI -…
2025 Corporate Equality Index assesses LGBTQ+ workplace equality GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ --…
A Representation of the Best in Simulation Healthcare Education in 2024 ORLANDO, Fla., Jan. 7,…
Innovation & Entrepreneurship Leader to Accelerate ULP's Mission in Incubation, Acceleration, and Education IRVINE, Calif., Jan.…
TORRINGTON, Conn., Jan. 7, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…